1st Clinical Trial To Show Colesevelam HCl Plus Stable Oral Antidiabetic Drug Improves Glycemic Control In Type 2 Diabetes Patients

... The first data to demonstrate the effect of WelChol® (colesevelam hydrochloride) on glucose lowering was presented today at The American Diabetes Association's (ADA) 66th Annual Scientific Sessions in Washington, DC. WelChol treatment resulted in a mean 0.5% reduction in A1C versus placebo (p=0.007). Moreover, in patients with A1C 8.0%, WelChol lowered A1C by 1.0% compared to placebo (p=0.002). [click link for full article] ...